Palomar recognizes that visitors to this site and with whom we conduct business value their privacy. Often, however, the collection of personal information is necessary and desirable both for the visitor and Palomar. Thus, in some circumstances Palomar may request personal information from you, like your name, e-mail address, company name, title, address and/or telephone number. Your response to these inquiries is strictly voluntary. Once submitted, Palomar may use this information to customize your experience on this site and for other business purposes, such as sending you information about Palomar and Palomar's products. Palomar will not sell, rent, or share your information with any other organization.

In general, you can visit our site without divulging any personal information. Certain areas, however, require specific information and may not be available to visitors who choose not to provide such information.  

Palomar automatically collects domain information and pages accessed from all visitors to this site as part of its on-going administration of this site. This data helps Palomar understand more about the types of visitors accessing this site, how often they visit and what parts of the site they visit most often. Palomar may then use this information to modify and improve the site.

Palomar may modify or update this Privacy Statement at any time without notice.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act
With the exception of the historical information contained in Palomar's web site, the matters described herein contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the Company's current expectations, plans, intentions, beliefs or predictions. These forward-looking statements are neither promises nor guarantees, but involve risk and uncertainties that may individually or mutually impact the matters herein, and cause actual results, events and performances to differ materially from such forward-looking statements. These risk factors include, but are not limited to, results of future operations, technological difficulties in developing or introducing new products, the results of future research, lack of product demand and market acceptance for current and future products, the effect of economic conditions, challenges in managing joint ventures and research with third parties and government contracts, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will be obtained for future products and additional applications, the results of litigation, including patent infringement lawsuits, difficulties in collecting royalties, potential infringement of third-party intellectual property rights, factors affecting the Company's future income and resulting ability to utilize its NOLs, and/or other factors, which are detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended December 31, 2010 and the Company's quarterly reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.